CSF2 and chronic myelogenous leukemia, BCR-ABL1 positive: Imiquimod also exerts therapeutic effects on chronic myeloid leukemia (CML) patients when administered together with a granulocyte macrophage-colony stimulating factor (GM-CSF) producing-vaccine derived from a CML cell line [5].